3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Urinary Bladder Neoplasms
1
Sarcoma, Ewing
1
Recurrence
1
Rectal Diseases
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Nasopharyngeal Carcinoma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Graft vs Host Disease
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric Cancer With Liver Metastases
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colonic Neoplasms
1
Colonic Diseases
1
Interventions
pembrolizumab
6
Nivolumab
6
enfortumab vedotin
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Ipilimumab
4
sacituzumab govitecan
3
Docetaxel
3
CTLA-4 Antigen
3
cabozantinib
2
Taxes
2
Paclitaxel
2
Gemcitabine
2
relatlimab
1
eribulin
1
avelumab
1
atezolizumab
1
Single Person
1
Radiosurgery
1
Platinum
1
Cisplatin
1
Carboplatin
1
Axitinib
1
Antineoplastic Protocols
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Drug Therapy
×
30 days
×
Clear all
No trials found.